This is a working overview of DAC linker, written for readers who want more than a one-paragraph summary but less than a textbook.
Reviewed 2025-10-20. Anything still debated is marked as such rather than presented as settled.
CJC-1295 is a synthetic analogue of growth hormone-releasing hormone, built on the 29-amino-acid GHRH(1-29) fragment. Four substitutions distinguish it from the natural sequence: D-alanine at position 2, glutamine at position 8, alanine at position 15, and leucine at position 27. These changes reduce enzymatic cleavage and extend the peptide's persistence in circulation. The compound is discussed in two forms, one carrying a drug affinity complex and one without it.
The drug affinity complex is a maleimidopropionic acid group attached to a lysine side chain. It reacts with the free thiol of cysteine-34 on circulating albumin, forming a covalent bond. This conjugation keeps the peptide in the bloodstream and shields it from rapid renal filtration and proteolysis. Reported circulation half-lives for the albumin-bound form fall in the range of roughly six to nine days in early human studies.
CJC-1295 belongs to a class of synthetic peptides modeled on growth hormone releasing hormone, a forty-four amino acid signal produced by the hypothalamus. The compound is built from the first twenty-nine residues of the natural sequence, with four substitutions introduced at positions 2, 8, 15 and 27. These changes were designed to slow enzymatic breakdown while preserving receptor activation. The result is a peptide that is shorter than native GHRH and considerably more resistant to ordinary clearance pathways in circulation.
Two related forms appear under the CJC-1295 name. The simpler analogue, commonly written as modified GRF(1-29), carries the four substitutions but no additional conjugation. The second form attaches a maleimidopropionic acid linker to a lysine residue, a modification frequently called the drug affinity complex. That linker reacts with the free thiol on serum albumin to form a covalent bond. Because albumin has a long residence time in blood, the conjugated peptide stays in circulation far longer than the unconjugated analogue.
| Property | Value | Notes |
|---|---|---|
| Physical form | Lyophilized white powder | Supplied as a freeze-dried solid for research use |
| Molecular weight | Approximately 3,647 Da (DAC form) | Lower for the variant lacking the albumin-binding moiety |
| Solubility | Soluble in water and aqueous buffer | Typically dissolved in sterile or bacteriostatic water |
| Typical storage temperature | −20 °C or below | Dry powder, desiccated and protected from light |
| Common analytical method | Reversed-phase HPLC with mass spectrometry | Used for purity estimation and identity confirmation |
CJC-1295 is a synthetic peptide designed as a long-acting analogue of growth hormone-releasing hormone (GHRH). Its structure derives from the first 29 amino acids of native GHRH, a fragment often called GRF(1-29). Four substitutions were introduced to slow enzymatic breakdown and extend activity relative to the natural sequence. The compound was developed by ConjuChem as part of a broader effort to improve the pharmacokinetic profile of peptide hormones. It is studied in laboratory and clinical research settings rather than appearing as a naturally occurring substance.
Two related forms circulate in technical discussion under the same family name. The original version carries a drug affinity complex (DAC) that binds covalently to serum albumin after administration, and this linkage substantially extends circulation time. A second form, frequently written as modified GRF(1-29) or CJC-1295 without DAC, lacks that linker and clears much faster. The naming is a frequent source of confusion because the shorthand CJC-1295 can refer to either form depending on the source. Reports sometimes fail to specify which variant was studied.
CJC-1295 acts at the growth hormone-releasing hormone receptor, a G-protein-coupled receptor found on somatotroph cells in the anterior pituitary. Binding triggers a rise in cyclic AMP and calcium entry, which promotes release of stored growth hormone. Because the peptide mimics the body's own releasing hormone, it amplifies existing secretory pulses rather than driving continuous output. The size of the response therefore depends partly on the subject's own hormonal rhythm and feedback state.
The attached maleimide group explains the unusual duration of the DAC version. After injection it reacts with the thiol of cysteine-34 on serum albumin, forming a stable covalent bond. The resulting conjugate is too large for rapid kidney filtration and is shielded from many peptidases. Reported half-lives for this form reach several days, whereas the version without the group is cleared in roughly half an hour. That gap is the main pharmacological difference between the two.
Ronnie O'Sullivan wins the 2024 Masters after beating Ali Carter, making him both the youngest and oldest winner in the tournament's history. He won his first title in the 1995 Masters when he was 19 years old. 29 years later, he wins his eighth at the age of 48. 15 January The portrait of King Charles III for use on public buildings, such as courts and government offices is unveiled. Another week of strike action is announced by the ASLEF train drivers union, to run from Tuesday 30 January until Monday 5 February. The Home Office announces that it will proscribe the radical Islamist group Hizb ut-Tahrir as a terrorist organisation, accused of praising the Hamas attacks. A review into investigations conducted by Greater Manchester Police between 2004 and 2019 finds that girls were "left at the mercy" of paedophile grooming gangs for several years because of failings by senior police and council bosses. Alison Phillips confirms she will stand down as editor of the Daily Mirror at the end of January, having been in the role since 2018. 16 January Schools are closed and commuters face disruption following snowfall across parts of the UK. Lee Anderson and Brendan Clarke-Smith resign their positions as Deputy Chairmen of the Conservative Party, after saying they would back rebel amendments on the Rwanda bill. Jane Stevenson also resigns as a Parliamentary Private Secretary so she can vote for the amendment.
Dipicolinic acid (pyridine-2,6-dicarboxylic acid or PDC and DPA) is a chemical compound which plays a role in the heat resistance of bacterial endospores. It is also used to prepare dipicolinato ligated lanthanide and transition metal complexes for ion chromatography.
In May 2024, Cerebras in collaboration with researchers from Sandia National Laboratories, Lawrence Livermore National Laboratory, Los Alamos National Laboratory, and the National Nuclear Security Administration, simulated 800,000 atoms interacting with each other, calculating the interactions in increments of one femtosecond at a time. Each step took just microseconds to compute on the Cerebras WSE-2, much faster than on the Frontier supercomputer. Cerebras was named to the "100 Most Influential Companies list" by Time in May 2024. In June 2024, Cerebras announced a collaboration with Dell Technologies, for AI compute infrastructure for generative AI. In August 2024, Cerebras launched its AI inference service, which it claimed to be ten to twenty times faster than systems built using Nvidia's H100 Hopper graphics processing units. In January 2025, the Mayo Clinic announced a collaboration with Cerebras to combine genomic data with de-identified data from patient records and medical evidence to explore the ability to predict a patient's response to treatments to manage disease. In January 2025, Cerebras announced support for DeepSeek's R1 70B reasoning model at 1,600 tokens/second. In February 2025, Mistral AI began using Cerebras products to power its Le Chat service and reached a speed record. Also in February 2025, Cerebras announced a partnership with Perplexity AI's Sonar model, which runs on Cerebras chips at 1,200 tokens per second.
Sources: en.wikipedia.org
==== United Nations Climate Change Conference ==== On 1 November 2022, the COP27 host Egypt invited then President-elect Lula to visit the summit which raised hopes among climate activists and international organizations officials that Brazil will strengthen its environmental policies. Lula accepted the invitation and, while attending the COP27, promised to fight for a zero deforestation in the Amazon and other biomes. He also promised to have a United Nations Climate Change conference held in the Amazon. On 11 January 2023, Lula announced Brazil was making an official bid for the Brazilian city of Belém to host the COP 30. In May 2023, the UN announced that Belém had been chosen to host the summit, a first for a city in the Amazon region. During the COP28, Lula announced that Brazil would join the OPEC+ initiative, which focuses on integration and discussion between members of the group and other countries. He also announced a plan to recover degraded pasturelands, and to boost overall agriculture productivity through loans by Brazil's BNDES.
== Ligands == Several selective ligands for the oxytocin receptor have been developed, but close similarity between the oxytocin and related vasopressin receptors make it difficult to achieve high selectivity with peptide derivatives. However the search for a druggable, non-peptide template has led to several potent, highly selective, orally bioavailable oxytocin receptor antagonists. Oxytocin receptor agonists have also been developed.
The Sindh government under PPP abolished child marriages by making the legal marriage age eighteen years in the province under the Sindh Child Marriages Restraint Act, 2013. He as a member of the opposition in the National Assembly has also advocated that the legal marriage age should be made eighteen years across the country. On 4 May 2019 he tweeted, "UAE marriage age is 18, Indonesia is 18, and Turkey is also 18. Are they not Muslim countries? In Sindh where marriage age is 18, we saw how law stopped an adult marrying a 10-year-old! Every 20 minutes a girl dies in Pakistan as a result of underage pregnancy.
Sources: en.wikipedia.org
The two share the same 29-amino-acid backbone. CJC-1295 carries an additional albumin-binding moiety that markedly extends its residence time in circulation, while the form without that moiety clears faster. Literature sometimes applies the name loosely to either variant.
It has not been approved by major regulatory agencies for any therapeutic indication. Material sold under this name is typically distributed for laboratory research only. Clinical use is not supported by large controlled trials.
Early human studies of the albumin-binding form reported circulation half-lives on the order of several days. The value depends on assay method and study design. Estimates for the form without the binding moiety are considerably shorter.
The names are often used interchangeably in casual writing, but they are not strictly identical. Modified GRF(1-29) refers to the unconjugated analogue carrying only the four substitutions. The version sold as CJC-1295 with DAC includes the albumin binding linker and clears much more slowly.